DOPATAS-10MG

Uses of DOPATAS-10MG

DOPATAS-10MG is prescribed for various conditions, primarily focusing on metabolic and cardiovascular health.

• Type 2 Diabetes Mellitus

  DOPATAS-10MG is used to improve glycemic control in adults with type 2 diabetes. It helps lower high blood sugar levels by increasing glucose excretion through the urine, working alongside diet and exercise to manage the condition effectively and reduce the risk of diabetes-related complications.

• Heart Failure

  This medication is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults, regardless of whether they have type 2 diabetes. It is effective in patients with heart failure with reduced ejection fraction (HFrEF) and also in those with preserved ejection fraction (HFpEF).

• Chronic Kidney Disease

  DOPATAS-10MG is used to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease, with or without type 2 diabetes. It helps protect kidney function and slow disease progression.

Side Effects of DOPATAS-10MG

Like all medicines, DOPATAS-10MG can cause side effects, although not everybody gets them. Most side effects are mild to moderate and temporary.

Serious but rare side effects may occur. Seek immediate medical attention if you experience any of the following:

If any side effect bothers you or does not go away, please consult your doctor. Do not stop taking the medication without medical advice.

How to use DOPATAS-10MG

• Adults:

  The recommended starting dose of DOPATAS-10MG is 10mg once daily, taken orally in the morning, with or without food. The dose may be adjusted by your doctor based on your kidney function and individual response. Do not exceed the prescribed dose.

• Children:

  DOPATAS-10MG is generally not recommended for use in children and adolescents below 18 years of age, as its safety and efficacy have not been established in this population. Consult a pediatrician for appropriate treatment options.

• Elderly:

  No dose adjustment is required based on age alone. However, elderly patients (65 years and older) may be more susceptible to volume depletion and impaired renal function. Close monitoring of hydration status and kidney function is advisable. Consult your doctor for personalized advice.

• Missed Dose:

  If you miss a dose of DOPATAS-10MG, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. Consult your doctor if you have any concerns.

How DOPATAS-10MG works

Dapagliflozin, the active ingredient in DOPATAS-10MG, belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. SGLT2 is a protein primarily found in the kidneys, responsible for reabsorbing most of the glucose that has been filtered from the blood back into the bloodstream. By selectively inhibiting SGLT2, Dapagliflozin prevents this reabsorption, leading to increased excretion of glucose in the urine. This process effectively lowers blood glucose levels in patients with type 2 diabetes. This unique mechanism of action is independent of insulin secretion and sensitivity, making it effective even in patients with declining beta-cell function. The increased urinary glucose excretion also results in caloric loss, which can contribute to modest weight reduction. Additionally, the osmotic diuresis induced by Dapagliflozin can lead to a slight reduction in blood pressure. These combined effects contribute to its beneficial impact on cardiovascular and renal outcomes, offering comprehensive protection beyond just blood sugar control.

Precautions

• Inform your doctor about all your medical conditions, especially kidney or liver problems.
• Maintain adequate hydration to prevent dehydration, especially in hot weather or during illness.
• Be aware of the symptoms of diabetic ketoacidosis (DKA) and seek immediate medical attention if they occur.
• Monitor for symptoms of urinary tract infections or genital yeast infections and report them to your doctor.
• Exercise caution if you are undergoing surgery, as temporary discontinuation of the medication may be required.
• Inform your doctor about all other medications you are taking, including over-the-counter drugs and herbal supplements.

Safety Advice

Alcohol

CAUTION

Alcohol consumption may increase the risk of hypoglycemia (low blood sugar) and diabetic ketoacidosis (DKA) when taking DOPATAS-10MG. It is advisable to limit or avoid alcohol intake and discuss this with your doctor.

Pregnancy

UNSAFE

DOPATAS-10MG is not recommended during pregnancy, especially during the second and third trimesters, as it may harm the developing fetus. Consult your doctor immediately if you are pregnant or planning to conceive.

Breastfeeding

UNSAFE

It is unknown whether Dapagliflozin passes into breast milk. Due to potential risks to the infant, breastfeeding is not recommended while taking DOPATAS-10MG. Discuss alternative feeding options with your doctor.

Driving

SAFE

DOPATAS-10MG generally does not affect your ability to drive. However, if you experience symptoms of hypoglycemia (dizziness, weakness), which can occur when combined with other antidiabetic drugs, avoid driving and operating machinery.

Kidney

CAUTION

DOPATAS-10MG is processed by the kidneys. Dose adjustments or discontinuation may be necessary based on your kidney function. Regular monitoring of kidney parameters is crucial, especially in patients with pre-existing kidney impairment.

Liver

CAUTION

Patients with severe liver impairment should use DOPATAS-10MG with caution. While no dose adjustment is typically needed for mild to moderate impairment, close monitoring is recommended. Consult your doctor for specific guidance.

Fact Box

Frequently asked questions by patients

Frequently Asked Questions

Additional Information